Neoantigen-Based Cancer Immunotherapy: One Step Closer to the Promise of Personalized Medicine
Back Bay Report on Neoantigen-Based Cancer Immunotherapy
Blog, Jonathan Gertler Posts, Michelle Hoffmann Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsASCO, Cancer, CART-T, immuno-oncology, Neoantigens, Oncology, T Cell, White Paper
